Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population

• मुख्य लेखकों: Rebecca K. Hollenberg (लेखक), Diane R. Krieger (लेखक), Robert Samuels (लेखक), Kim Kraynyak (लेखक), Albert Sylvester (लेखक), Matthew Morrow (लेखक), Jean Boyer (लेखक), Michael Dallas (लेखक), Prakash K. Bhuyan (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2020-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

HPV remains the most common sexually transmitted disease worldwide, despite improvements in awareness, screening, prophylactic vaccination uptake, and surgical treatment. VGX-3100 is an immunotherapy that uses electroporation to introduce DNA encoding for modified HPV-16 and HPV-18, E6-and E7 protei...